- Home
- SYK
as 08-01-2025 4:00pm EST
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
| Founded: | 1941 | Country: | United States |
| Employees: | N/A | City: | PORTAGE |
| Market Cap: | 142.6B | IPO Year: | N/A |
| Target Price: | $426.83 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.55 | EPS Growth: | -15.81 |
| 52 Week Low/High: | $314.93 - $406.19 | Next Earning Date: | 07-31-2025 |
| Revenue: | $23,818,000,000 | Revenue Growth: | 11.36% |
| Revenue Growth (this year): | 10.75% | Revenue Growth (next year): | 8.35% |
Stock Insider Trading Activity of Stryker Corporation (SYK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Berry William E Jr | SYK | VP, Chief Accounting Officer | May 12 '25 | Sell | $388.56 | 1,241 | $482,202.34 | 2,833 | |
| STRYKER RONDA E | SYK | Director10% Owner | May 6 '25 | Sell | $377.01 | 200,000 | $75,391,847.89 | 3,596,664 |
Latest Stryker Corporation News
SYK Breaking Stock News: Dive into SYK Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Evercore ISI Adjusts Price Target on Stryker to $418 From $415, Maintains Outperform Rating
MT Newswires
a day ago
Bernstein Adjusts Price Target on Stryker to $455 From $450, Maintains Outperform Rating
MT Newswires
a day ago
Baird Adjusts Price Target on Stryker to $450 From $436, Maintains Outperform Rating
MT Newswires
a day ago
Needham Adjusts Price Target on Stryker to $448 From $442, Maintains Buy Rating
MT Newswires
a day ago
BTIG Adjusts Price Target on Stryker to $407 From $413, Maintains Buy Rating
MT Newswires
a day ago
Wells Fargo Adjusts Price Target on Stryker to $445 From $435, Maintains Overweight Rating
MT Newswires
a day ago
Wolfe Research Adjusts Price Target on Stryker to $430 From $405, Maintains Outperform Rating
MT Newswires
a day ago
Goldman Sachs Adjusts Price Target on Stryker to $430 From $418
Compare SYK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SYK Stryker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.